CVE-2025-61940

| EUVD-2025-200322 HIGH
2025-12-02 [email protected]
8.3
CVSS 3.1
Share

CVSS Vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L
Attack Vector
Network
Attack Complexity
Low
Privileges Required
Low
User Interaction
None
Scope
Unchanged
Confidentiality
High
Integrity
High
Availability
Low

Lifecycle Timeline

3
EUVD ID Assigned
Mar 15, 2026 - 14:04 euvd
EUVD-2025-200322
Analysis Generated
Mar 15, 2026 - 14:04 vuln.today
CVE Published
Dec 02, 2025 - 21:15 nvd
HIGH 8.3

Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

Analysis

CVE-2025-61940 is a security vulnerability (CVSS 8.3). High severity vulnerability requiring prompt remediation.

Technical Context

Vulnerability type not specified by vendor. CVSS 8.3 indicates high severity.

Affected Products

['Unspecified product']

Remediation

Monitor vendor channels for patch availability.

Priority Score

42
Low Medium High Critical
KEV: 0
EPSS: +0.1
CVSS: +42
POC: 0

Share

CVE-2025-61940 vulnerability details – vuln.today

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy